ArticleApplied microbiology and biotechnology2025
Nasal microbiota dysbiosis and functional alterations in children with adenoid hypertrophy: potential biomarkers and post-surgical microbial recovery.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nasopharyngeal swab transcriptomics identifies divergent molecular signatures in adenoid hypertrophy and allergic rhinitis comorbidity.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Nasal cavity and nasopharynx are habitats for both pathogenic and non-pathogenic bacteria. Adenoid hypertrophy (AH) is the main cause in children, with a high incidence, for the airflow reduction in the upper airways. However, limited research described the differences of nasal microbial compositions in AH patients and healthy children. To determine the association between nasal microbiota and AH, total DNAs were collected and extracted from the nasal cavity and the hypertrophic adenoid of the donors, and the 16S rRNA gene V3-V4 region was sequenced. Microbial diversity was compared between the healthy and AH groups, and the enriched functional pathways were predicted. Although the alpha-diversity of microbial communities did not show statistically significant differences between the groups, principal coordinate analysis (PCoA) revealed that the microbiota component in the nasal cavity as well as in the hypertrophic adenoid tissues of children with AH was significantly different from that of healthy children. Genera Alloiococcus, Moraxella, Streptococcus, and Bacteroides were specifically enriched in the AH group's samples, among which Moraxella spp. was significantly enriched in both nasal cavity and adenoid tissues, indicating a potential association of it with AH. In addition, Tax4fun prediction revealed disordered microbial functions in AH children. Nutrient metabolism, signaling system, chemotactic reaction, genetic replication, and reproduction-related pathways significantly decreased in the AH group but increased after adenoidectomy treatment. This study revealed a high association between specific microorganisms and AH disease. Future work is needed to investigate the role of Moraxella spp. in AH development. KEY POINTS: • Microbiota in the nasal cavity has high specificity in distinguishing patients with adenoidal hypertrophy from healthy individuals, indicating that the homeostasis of microbiota in the nasal cavity is highly associated with the healthy status of adenoid. • Several bacterial taxa, including Alloiococcus, Moraxella, Streptococcus, and Bacteroides, are bio-markers for adenoidal hypertrophy, which enriches specifically in both nasal cavities and hypertrophied adenoid tissues of patients. • In the nasal cavity of patients with adenoidal hypertrophy, microbial functions related to pathogenicity were enriched, indicating an association between adenoidal hypertrophy and disorder of microbiota in the nasal cavity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.